| Popis: |
Following the administration of a radiopharmaceutical, the patient is essentially a mobile source of radiation. The hazards from the patient are contamination from radioactive tissue/body fluids, and exposure to the radiation emitted from the patient. These hazards present a risk to the patient due to self-absorbed radiation, healthcare workers, other patients, members of the public, family members (including the foetus), colleagues at work, and carers. This chapter presents the methodology used for assessing the doses to patients and critical groups, and discusses its limitations. It considers the risks and protective measures for: the patient (both adults and paediatrics), the foetus and young children including reproduction, breastfeeding, and close contact, hospital and external workers who may come into contact with the patient or be at risk of contamination, and the general public (inside and outside the hospital environment). The risks are presented along with practical guidance to minimize the hazard. |
